Free Trial

Rentokil Initial plc (NYSE:RTO) Shares Bought by Arvin Capital Management LP

Rentokil Initial logo with Business Services background

Arvin Capital Management LP lifted its stake in Rentokil Initial plc (NYSE:RTO - Free Report) by 33.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 173,600 shares of the company's stock after purchasing an additional 43,600 shares during the quarter. Rentokil Initial comprises about 1.2% of Arvin Capital Management LP's portfolio, making the stock its 23rd largest holding. Arvin Capital Management LP's holdings in Rentokil Initial were worth $4,396,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Cape Investment Advisory Inc. raised its holdings in shares of Rentokil Initial by 65.2% in the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock worth $38,000 after buying an additional 594 shares during the last quarter. CENTRAL TRUST Co raised its stake in Rentokil Initial by 15,208.3% in the 4th quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock worth $47,000 after acquiring an additional 1,825 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Rentokil Initial by 486.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock worth $49,000 after acquiring an additional 1,611 shares during the period. Cromwell Holdings LLC purchased a new stake in Rentokil Initial during the 4th quarter valued at about $59,000. Finally, Blue Trust Inc. increased its holdings in shares of Rentokil Initial by 140.4% in the fourth quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock valued at $60,000 after purchasing an additional 1,403 shares during the period. 9.91% of the stock is currently owned by institutional investors and hedge funds.

Rentokil Initial Stock Performance

NYSE RTO traded up $0.27 on Friday, reaching $23.03. 431,637 shares of the company's stock traded hands, compared to its average volume of 766,660. The stock has a 50 day moving average price of $22.90 and a 200-day moving average price of $24.43. The firm has a market cap of $11.63 billion, a price-to-earnings ratio of 15.25, a P/E/G ratio of 7.95 and a beta of 1.07. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. Rentokil Initial plc has a fifty-two week low of $19.60 and a fifty-two week high of $34.07.

Rentokil Initial Dividend Announcement

The business also recently announced a semi-annual dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 4th will be paid a $0.3825 dividend. The ex-dividend date of this dividend is Friday, April 4th. This represents a dividend yield of 2.4%. Rentokil Initial's payout ratio is 43.71%.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a report on Friday, March 7th. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy".

Get Our Latest Report on Rentokil Initial

Rentokil Initial Profile

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

See Also

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Should You Invest $1,000 in Rentokil Initial Right Now?

Before you consider Rentokil Initial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.

While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines